Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.

Saved in:

Bibliographic Details
Title:	Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.
Authors:	Mascolo A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Di Napoli R; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Balzano N; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., D'Alessio E; Pharmacy Unit, Ospedale del Mare-A.S.L. Na1-Centro, Naples, Italy., Izzo I; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Rossi F; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Paolisso G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy., Capuano A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Sportiello L; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Source:	Frontiers in pharmacology [Front Pharmacol] 2023 Aug 16; Vol. 14, pp. 1229304. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2023.1229304